CERE

Cerevel Therapeutics Holdings, Inc. Common Stock

Delisted

CERE was delisted on the 31st of July, 2024.

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$286

Top Sellers

1 -$2.69B
2 -$441M
3 -$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change
Change in
Stake
PHS
176
Pekin Hardy Strauss
Illinois
CC
177
Corton Capital
Ontario, Canada
HHGC
178
Hunting Hill Global Capital
New York
Deutsche Bank
179
Deutsche Bank
Germany
ET
180
Entropy Technologies
New York
MSRPS
181
Maryland State Retirement & Pension System
Maryland
CIBC Asset Management
182
CIBC Asset Management
Ontario, Canada
GH
183
GAM Holding
Switzerland
QOP
184
Quinn Opportunity Partners
Virginia
Fidelity Investments
185
Fidelity Investments
Massachusetts
AB
186
Amalgamated Bank
New York
MIM
187
MetLife Investment Management
New Jersey
Macquarie Group
188
Macquarie Group
Australia
Royal Bank of Canada
189
Royal Bank of Canada
Ontario, Canada
TSMHT
190
Thurston Springer Miller Herd & Titak
Indiana
CF
191
Centaurus Financial
California
CFM
192
Catalyst Funds Management
Australia
KBC Group
193
KBC Group
Belgium
PCWA
194
Pacific Capital Wealth Advisors
California
LIM
195
Longfellow Investment Management
Massachusetts
Wells Fargo
196
Wells Fargo
California
CF
197
Corebridge Financial
Texas
Russell Investments Group
198
Russell Investments Group
United Kingdom
Pacer Advisors
199
Pacer Advisors
Pennsylvania
Nisa Investment Advisors
200
Nisa Investment Advisors
Missouri